The contact comprises at least 3 antibody drugs and can be stepped up to 400 million USD investment upon reaching milestones, the largest US-China pharmaceutical deal ever.
Nikkei Biotech news release, April 20, 2014
The contact comprises at least 3 antibody drugs and can be stepped up to 400 million USD investment upon reaching milestones, the largest US-China pharmaceutical deal ever.
Nikkei Biotech news release, April 20, 2014
This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny